Obesity is not listed as a chronic PMB condition, and its not included under any of the 271 medical emergencies or 26 chronic diseases
The choice between these medications requires a thoughtful evaluation of individual needs, priorities, and treatment goals, underscoring the importance of personalized medicine in navigating the landscape of GLP-1 receptor agonists
Retatrutide belongs in protocols examining GCGR biology in conjunction with incretin signaling, particularly hepatic metabolic pathways
11 While a number of different non-medication options exist for treatment of OSA, including lifestyle modifications, breathing devices, oral appliances, and surgical procedures, tirzepatide was approved by the FDA for moderate to severe obstructive sleep apnea in late 2024
Semaglutide produces significant weight loss, but its not a miracle cure